Ann Lab Med.  2014 May;34(3):256-258. 10.3343/alm.2014.34.3.256.

The First Korean Case of Moraxella osloensis Bacteremia in a Patient with Acute Myeloid Leukemia

Affiliations
  • 1Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea. trust99@snu.ac.kr

Abstract

No abstract available.


MeSH Terms

Aged
Ampicillin/therapeutic use
Anti-Bacterial Agents/therapeutic use
Antimetabolites, Antineoplastic/therapeutic use
Asian Continental Ancestry Group
Cytarabine/therapeutic use
Drug Therapy, Combination
Humans
Idarubicin/therapeutic use
Leukemia, Myeloid, Acute/complications/*diagnosis/drug therapy
Male
Moraxella/genetics/*isolation & purification
Moraxellaceae Infections/*diagnosis/drug therapy/microbiology
RNA, Ribosomal, 16S/chemistry/genetics
Republic of Korea
Respiratory Tract Infections/diagnosis/microbiology
Sequence Analysis, RNA
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Sulbactam/therapeutic use
Ampicillin
Anti-Bacterial Agents
Antimetabolites, Antineoplastic
RNA, Ribosomal, 16S
Cytarabine
Idarubicin
Sulbactam

Figure

  • Fig. 1 Colonial and microscopic morphology of Moraxella osloensis. (A) Gram-negative coccobacilli from positive aerobic blood culture smear preparations (Gram stain, ×1,000). (B) Grey-white colored colonies on blood agar plate. (C) Gram-negative coccobacilli from blood agar plate smear preparations (Gram stain, ×1,000).


Reference

1. Vaneechoutte M, Dijkshoorn L, Nemec A, Kämpfer P, Wauters G. Acinetobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods. In : Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of clinical microbiology. 10th ed. Washington, D.C: American Society for Microbiology;2011. p. 714–738.
2. Han XY, Tarrand JJ. Moraxella osloensis blood and catheter infections during anticancer chemotherapy: clinical and microbiologic studies of 10 cases. Am J Clin Pathol. 2004; 121:581–587. PMID: 15080311.
3. Shah SS, Ruth A, Coffin SE. Infection due to Moraxella osloensis: case report and review of the literature. Clin Infect Dis. 2000; 30:179–181. PMID: 10619749.
4. Vuori-Holopainen E, Salo E, Saxen H, Vaara M, Tarkka E, Peltola H. Clinical "pneumococcal pneumonia" due to Moraxella osloensis: case report and a review. Scand J Infect Dis. 2001; 33:625–627. PMID: 11525360.
5. Berrocal AM, Scott IU, Miller D, Flynn HW Jr. Endophthalmitis caused by Moraxella osloensis. Graefes Arch Clin Exp Ophthalmol. 2002; 240:329–330. PMID: 11981649.
6. Sifri CD, Brassinga AK, Flohr T, Kinchen JM, Hazen KC, Sawyer RG, et al. Moraxella osloensis bacteremia in a kidney transplant recipient. Transpl Int. 2008; 21:1011–1013. PMID: 18662367.
7. Roh KH, Kim CK, Koh E, Kim MS, Yong D, Park SC, et al. Three cases of Moraxella osloensis meningitis: a difficult experience in species identification and determination of clinical significance. J Korean Med Sci. 2010; 25:501–504. PMID: 20191057.
8. Dien Bard J, Lewinski M, Summanen PH, Deville JG. Sepsis with prolonged hypotension due to Moraxella osloensis in a non-immunocompromised child. J Med Microbiol. 2011; 60:138–141. PMID: 20829400.
9. Hadano Y, Ito K, Suzuki J, Kawamura I, Kurai H, Ohkusu K. Moraxella osloensis: an unusual cause of central venous catheter infection in a cancer patient. Int J Gen Med. 2012; 5:875–877. PMID: 23109812.
10. Sugarman B, Clarridge J. Osteomyelitis caused by Moraxella osloensis. J Clin Microbiol. 1982; 15:1148–1149. PMID: 7107844.
11. Feigin RD, San Joaquin V, Middelkamp JN. Septic arthritis due to Moraxella osloensis. J Pediatr. 1969; 75:116–117. PMID: 5790392.
12. Stryker TD, Stone WJ, Savage AM. Renal failure secondary to Moraxella osloensis endocarditis. Johns Hopkins Med J. 1982; 150:217–219. PMID: 7087280.
13. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC;2008.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-third Informational supplement, M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute;2013.
15. Gray TJ, Thomas L, Olma T, Iredell JR, Chen SC. Rapid identification of Gram-negative organisms from blood culture bottles using a modified extraction method and MALDI-TOF mass spectrometry. Diagn Microbiol Infect Dis. 2013; 77:110–112. PMID: 23891220.
Article
16. Carbonnelle E, Grohs P, Jacquier H, Day N, Tenza S, Dewailly A, et al. Robustness of two MALDI-TOF mass spectrometry systems for bacterial identification. J Microbiol Methods. 2012; 89:133–136. PMID: 22425492.
Article
17. Graham DR, Band JD, Thornsberry C, Hollis DG, Weaver RE. Infections caused by Moraxella, Moraxella urethralis, Moraxella-like groups M-5 and M-6, and Kingella kingae in the United States, 1953-1980. Rev Infect Dis. 1990; 12:423–431. PMID: 2359906.
18. Rosenthal SL, Freundlich LF, Gilardi GL, Clodomar FY. In vitro antibiotic sensitivity of Moraxella species. Chemotherapy. 1978; 24:360–363. PMID: 699676.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr